Serum and urinary carnitine in children with cystic fibrosis

Journal Title: Progress in Health Sciences - Year 2013, Vol 3, Issue 1

Abstract

Purpose: Cystic fibrosis (CF) is inherited, congenital disease of multi-organ expression. Carnitine play a role as a lipid acid transporter to mitochondrium for beta-oxydation. Acylation of carnitine is inevitable for detoxication processes in cells. Low lean body mass In CF patients can lead to decreased levels. The aim of the study was the evaluation of free carnitine, acylcarnitine and acylcarnitine/free carnitine ratio in serum and urine of children with cystic fibrosis. Material and methods: The study was conducted in a group of 15 CF children (4 F, 11 M), aged 12.6 ±5.4 years. The serum for a control group was collected from 32 healthy children. Urine samples for control group was collected from 62 health children. Free carnitine and total carnitine was assessed using spectrophotomeric method in which acyl group is transferred from acetyl-CoA to carnitine by carnitine acetyltransferase (CAT). Acyl carnitine concentration and acylcarnitine/free carnitine ratio was counted using Schmidt- Sommerfeld and Seccombe equation. Results: In 12 CF patients (80%) free carnitine and total carnitine was below lower limit of normal (p<0.001). In 9 patients (60%) free carnitine level was ≤ 20 µmol/L, which can be clinically diagnosed. Acylcarnitine levels were also statistically lower in CF group (p<0.01). Acylcarinitie/free carnitine ratio did not differ between the groups (p=0.05). Urine excretion of free carnitine, total carnitine and acylcarnitine was lower in CF group (p<0.001). Conclusions: In CF pediatric patients statistically significant lower levels of free carnitine, total carnitine and acylcarnitine were observed in comparison to controls. Low urine excretion of free carnitine, total carnitine and acylcarnitine was lower in CF group. No correlation between serum and urine levels of free carnitine, total carnitine and acylcarnitine were observed.

Authors and Affiliations

A. Kępka, Ł. Minarowski Ł. , Napoleon Waszkiewicz, S. Chojnowska, L. Trochimowicz, K. Zwierz, E. Chyczewska, Sł. D. Szajda

Keywords

Related Articles

Wombs for rent, outsoursed pregnancies, baby farms - ethics and surrogate motherhood

The history of surrogacy is composed of cases of happy solving family problems, but also of conflicts and lawsuits concerning a child and his welfare. In modern times it became the next to adoptions additional possibilit...

Rat skin as an experimental model in medicine

Scientific experiments due to safety and ethical limitations regarding research human are often based on animal models. Rats are laboratory animals which are commonly used for these purposes. It should be remembered that...

Uncovering supplementary information from questionnaire inquiry on physical ability with the aim to develop psycho-educational intervention: An example of a study using the SF-36 questionnaire among convalescents after acute pancreatitis

Purpose: The aim of this paper was to complete a series of our own reports on health-related outcomes of rehabilitation following successful clinical therapy in Poland, based on data from a questionnaire survey using the...

&nbsp;Health prevention in tropics. A safe journey to Ghana

&nbsp;A significant increase in the number of Polish citizens travelling abroad, including tropical areas, has been noted in recent years. However, tourists are often not interested in prophylaxis before their journey, t...

&nbsp;Cardio-respiratory status of stone grinders and brick field workers from west Bengal, India

&nbsp;Introduction: Quartz crushing and brick making industry are informal and demands heavy manual labour. They are socio-economically backward and are unable to avail of social security’s scheme meant for protection of...

Download PDF file
  • EP ID EP69540
  • DOI -
  • Views 146
  • Downloads 0

How To Cite

A. Kępka, Ł. Minarowski Ł. , Napoleon Waszkiewicz, S. Chojnowska, L. Trochimowicz, K. Zwierz, E. Chyczewska, Sł. D. Szajda (2013). Serum and urinary carnitine in children with cystic fibrosis. Progress in Health Sciences, 3(1), 13-18. https://europub.co.uk/articles/-A-69540